FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
ANDRX CORP /DE/ [ ADRX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 09/07/2005 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Andrx common stock | 09/07/2005 | M | 41,500 | A | $2.74 | 69,879(1) | D | |||
Andrx common stock | 35,000(2) | D | ||||||||
Andrx common stock | 18,400 | I | Held Jointly with Spouse | |||||||
Andrx common stock | 4,800 | I | Held by Minor Children | |||||||
Andrx common stock | 31,250(3) | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (right to buy) | $2.74 | 09/07/2005 | M | 41,500 | (4) | 02/12/2006 | Andrx Group Common Stock | 41,500 | $0.00 | 0 | D |
Explanation of Responses: |
1. Includes 681 shares acquired by the reporting person under the Andrx Corporation Employee Stock Purchase Plan for the quarter ended June 30, 2005. |
2. Represents 35,000 restricted stock units (RSUs) granted to the reporting person on December 1, 2002. Subject to certain acceleration and other conditions set forth in his agreement, the shares underlying theses units vest in equal installments of 8,750 each on November 30, 2005, 2006, 2007 and 2008. Upon vesting, a portion of the vested shares may be withheld to satisfy applicable taxes. |
3. On April 14, 2005, Andrx Corporation granted the reporting person 31,250 RSUs, with each unit representing the right to acquire one share of Andrx Group common stock, of which 25,000 units vest in seven equal annual installments beginning one year from the date of grant and 6,250 units vest entirely on the fourth anniversary of the date of grant, but is subject to acceleration in whole or in part, if Andrx meets certain financial performance criteria. Upon vesting, a portion of the vested shares may be withheld to satisfy applicable taxes. |
4. Previously vested. |
Remarks: |
/s/ Angelo C. Malahias | 09/08/2005 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |